Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-26 Sale | 2025-12-29 5:36 pm | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 50,000 | $3.47 | $173,500 | 39,179 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-09 Option Award | 2026-11-12 4:10 pm | N/A N/A | IRulya Therapeutics Inc. | IRLA | Wise John Drayton Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2026-11-09 Option Award | 2026-11-12 4:10 pm | N/A N/A | IRulya Therapeutics Inc. | IRLA | Valentine James Elwood Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2026-11-09 Option Award | 2026-11-12 4:10 pm | N/A N/A | IRulya Therapeutics Inc. | IRLA | PATTERSON LEONE D Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2026-11-09 Option Award | 2026-11-12 4:10 pm | N/A N/A | IRulya Therapeutics Inc. | IRLA | Bonuccelli Catherine M. Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2026-11-09 Option Award | 2026-11-12 4:10 pm | N/A N/A | IRulya Therapeutics Inc. | IRLA | Militello John Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
Ownership | 2026-10-19 4:11 pm | N/A 2036-03-15 | IRulya Therapeutics Inc. | IRLA | Fandrick Keith R. Chief Operating Officer | 0 | $0 | 233,767 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:57 pm | N/A 2036-06-11 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 2,700 | $0 | 2,700 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 5:51 pm | N/A 2036-06-11 | Quince Therapeutics Inc. | QNCX | Senner Christopher J. Director | 2,700 | $0 | 2,700 (Direct) | View |
| 2026-05-18 Option Award | 2026-06-11 5:30 pm | N/A 2031-03-01 | Quince Therapeutics Inc. | QNCX | Roberts Brigette Chief Corp. Affairs Officer | 16,698,162 | $0 | 16,698,162 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 8:25 pm | N/A 2036-01-23 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO and CMO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 8:07 pm | N/A 2036-01-23 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 200,000 | $0 | 200,000 (Direct) | View |
| 2026-01-23 Option Award | 2026-01-23 8:05 pm | N/A 2036-01-23 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 365,000 | $0 | 365,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-21 6:14 pm | N/A 2036-01-02 | Quince Therapeutics Inc. | QNCX | Senner Christopher J. Director | 21,810 | $0 | 21,810 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-21 6:10 pm | N/A 2036-01-02 | Quince Therapeutics Inc. | QNCX | McLoughlin Margaret Director | 19,547 | $0 | 19,547 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-21 6:05 pm | N/A 2036-01-02 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 29,423 | $0 | 29,423 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-21 5:59 pm | N/A 2036-01-02 | Quince Therapeutics Inc. | QNCX | Bray June Director | 18,724 | $0 | 18,724 (Direct) | View |
| 2024-10-23 Other | 2025-12-29 5:34 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 8,918 | $0 | 98,097 (Direct) | View |
| 2025-12-10 Gift | 2025-12-12 5:07 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO and CMO | 739,885 | $0 | 994,885 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-08 08:12 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 25,280 | $0.94 | 606,715 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-08 08:12 am | N/A 2032-05-22 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 27,551 | $0 | 606,715 (Direct) | View |
| 2025-12-05 Exercise | 2025-12-08 08:12 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 2,271 | $0.55 | 606,715 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:48 am | 2025-06-18 2030-06-18 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 37,736 | $0.125 | 372,012 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:48 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 37,736 | $1.2 | 372,012 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:46 am | 2025-06-18 2030-06-18 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 7,548 | $0.125 | 137,557 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:46 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 7,548 | $1.2 | 137,557 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:43 am | 2025-06-18 2030-06-18 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO and CMO | 150,944 | $0.125 | 1,145,829 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:43 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO and CMO | 150,944 | $1.2 | 1,145,829 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:52 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | RYAN UNA S Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:38 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:36 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Senner Christopher J. Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:33 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:27 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | McLoughlin Margaret Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:14 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Patni Rajiv Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:07 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Bray June Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-01-28 Option Award | 2025-02-11 5:44 pm | N/A 2035-01-27 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 1,200,000 | $0 | 1,200,000 (Direct) | View |
| 2025-01-28 Option Award | 2025-02-11 5:43 pm | N/A 2035-01-27 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT | 300,000 | $0 | 300,000 (Direct) | View |
| 2025-01-28 Option Award | 2025-02-11 5:41 pm | N/A 2035-01-27 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO and CCO | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-08 7:33 pm | N/A 2035-01-02 | Quince Therapeutics Inc. | QNCX | McLoughlin Margaret Director | 31,613 | $0 | 31,613 (Direct) | View |